Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Unaudited Financial Results For The Quarter and half year Ended On september 30, 2026.

Date: 29/10/2026 Listing Compliance Department BSE Limited Phiroze Jeejeebhoy Tower, 25th Floor, Dalal Street, Mumbai – 400 001 Scrip Code: 538964 Subject: Prior Intimation of Board Meeting Respected Sir / Madam, Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of Mercury Laboratories Limited (‘the Company’) will be held on Thursday, November 05, 2026, inter alia, to consider and approve the Unaudited Financial Results for the quarter and half year ended on September 30, 2026. Further, as per the Company’s Code of Conduct for Prevention of Insider Trading, please note that, the ‘Trading Window’ has already been closed with effect from October 01, 2026 and shall continue to remain closed till 48 hours after the declaration of the unaudited financial results for the quarter and half year ended on September 30, 2026. You are requested to take the above information on records. Thanking You. Yours faithfully, For Mercury Laboratories Limited Krishna Shah Company Secretary & Compliance Officer